|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM336803850 |
003 |
DE-627 |
005 |
20231225232955.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2022 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.3928/23258160-20220124-02
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1122.xml
|
035 |
|
|
|a (DE-627)NLM336803850
|
035 |
|
|
|a (NLM)35148213
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Elwan, Mohamed M
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Impact of the Inverted Internal Limiting Membrane Flap Diameter on Large Idiopathic Macular Hole Closure
|b Comparative Randomized Study
|
264 |
|
1 |
|c 2022
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 08.04.2022
|
500 |
|
|
|a Date Revised 08.04.2022
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a BACKGROUND AND OBJECTIVE: To study the impact of the size of internal limiting membrane inverted flap on the rate and timing of large idiopathic macular hole (MH) closure
|
520 |
|
|
|a PATIENTS AND METHODS: A prospective randomized comparative study included patients with large idiopathic MH. Eligible eyes underwent pars plana vitrectomy with either inverted small flap (SF < 2 disc diameters) or inverted large flap (LF from 2 to 4 disc diameters). The primary outcome measure included the rate of MH closure at the sixth month. Secondary outcome measures included the timing of MH closure and best-corrected visual acuity
|
520 |
|
|
|a RESULTS: Twenty-five eyes were included: 13 in the SF group and 12 in the LF group. At 6 months, the rate of closure was 84.6% in the SF group and 91.6% in the LF group, with no significant difference. Timing of closure was significantly shorter with LF, with better postoperative best-corrected visual acuity
|
520 |
|
|
|a CONCLUSION: LF offered a shorter duration for closure with better visual outcomes in large idiopathic MH. [Ophthalmic Surg Lasers Imaging Retina. 2022;53:103-107.]
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Randomized Controlled Trial
|
700 |
1 |
|
|a Hagras, Sherein M
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Ophthalmic surgery, lasers & imaging retina
|d 2013
|g 53(2022), 2 vom: 11. Feb., Seite 103-107
|w (DE-627)NLM224956647
|x 2325-8179
|7 nnns
|
773 |
1 |
8 |
|g volume:53
|g year:2022
|g number:2
|g day:11
|g month:02
|g pages:103-107
|
856 |
4 |
0 |
|u http://dx.doi.org/10.3928/23258160-20220124-02
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_63
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_90
|
912 |
|
|
|a GBV_ILN_91
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_135
|
912 |
|
|
|a GBV_ILN_136
|
912 |
|
|
|a GBV_ILN_151
|
912 |
|
|
|a GBV_ILN_181
|
912 |
|
|
|a GBV_ILN_203
|
912 |
|
|
|a GBV_ILN_217
|
912 |
|
|
|a GBV_ILN_235
|
912 |
|
|
|a GBV_ILN_289
|
912 |
|
|
|a GBV_ILN_294
|
912 |
|
|
|a GBV_ILN_297
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_352
|
912 |
|
|
|a GBV_ILN_674
|
912 |
|
|
|a GBV_ILN_676
|
912 |
|
|
|a GBV_ILN_688
|
912 |
|
|
|a GBV_ILN_698
|
912 |
|
|
|a GBV_ILN_721
|
912 |
|
|
|a GBV_ILN_737
|
912 |
|
|
|a GBV_ILN_791
|
912 |
|
|
|a GBV_ILN_812
|
951 |
|
|
|a AR
|
952 |
|
|
|d 53
|j 2022
|e 2
|b 11
|c 02
|h 103-107
|